KARYOPHARM THERAPEUTICS INC (KPTI) Stock Analyst Earnings Estimates
NASDAQ:KPTI - Nasdaq - US48576U1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 209.8M 94.08% | 157.1M -25.12% | 146.033M -7.04% | 152.56M 4.47% | 163.77M 7.35% | 199.24M 21.66% | 290.24M 45.67% | 371.16M 27.88% | 482.68M 30.05% | 585.21M 21.24% | 675.74M 15.47% | 726.77M 7.55% | |
| EBITDA YoY % growth | -97.51M 42.95% | -141.58M -45.20% | -129.01M 8.88% | -163.2M -26.50% | -132.6M 18.75% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -98.3M 42.82% | -142.2M -44.66% | -129.54M 8.90% | -118.203M 8.75% | -104.404M 11.67% | -75.246M 27.93% | -60.792M 19.21% | 20.336M 133.45% | 109.87M 440.27% | 191.46M 74.26% | 274.8M 43.53% | 318.38M 15.86% | |
| Operating Margin | -46.85% | -90.52% | -88.71% | -77.48% | -63.75% | -37.77% | -20.95% | 5.48% | 22.76% | 32.72% | 40.67% | 43.81% | |
| EPS YoY % growth | -1.71 37.36% | -2.03 -18.71% | -1.25 38.42% | -0.65 46.40% | -0.73 -9.39% | -0.55 24.39% | -0.24 56.75% | -0.06 74.47% | 0.23 483.33% | 0.50 115.22% | 0.53 5.05% | 0.59 11.54% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 17.13% | -0.10 -169.70% | -0.23 11.73% | -0.22 9.69% |
| Revenue Q2Q % growth | 37.096M 11.98% | 40.472M -5.41% | 40.112M 3.43% | 39.788M 30.28% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.878M 11.50% | -26.901M 4.34% | -27.987M -6.48% | -28.751M -1.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.24 33.33% | -0.27 | 0.03 | 10.00% |
| Q3 2024 Q2Q % growth | -0.26 13.33% | -0.27 | 0.01 | 3.03% |
| Q2 2024 Q2Q % growth | 0.15 151.72% | -0.30 | 0.45 | 149.25% |
| Q1 2024 Q2Q % growth | -0.32 -6.67% | -0.34 | 0.02 | 6.03% |
| Q4 2023 Q2Q % growth | -0.36 16.28% | -0.32 | -0.04 | -13.96% |
| Q3 2023 Q2Q % growth | -0.30 33.33% | -0.29 | -0.01 | -5.04% |
| Q2 2023 Q2Q % growth | -0.29 53.23% | -0.35 | 0.06 | 16.92% |
| Q1 2023 Q2Q % growth | -0.30 43.40% | -0.38 | 0.08 | 20.12% |
| Q4 2022 Q2Q % growth | -0.43 -193.48% | -0.36 | -0.07 | -19.42% |
| Q3 2022 Q2Q % growth | -0.45 34.78% | -0.58 | 0.13 | 21.99% |
| Q2 2022 Q2Q % growth | -0.62 12.68% | -0.65 | 0.03 | 4.02% |
| Q1 2022 Q2Q % growth | -0.53 31.17% | -0.64 | 0.11 | 17.65% |
| Q4 2021 Q2Q % growth | 0.46 177.97% | -0.53 | 0.99 | 187.47% |
| Q3 2021 Q2Q % growth | -0.69 5.48% | -0.69 | 0.00 | -0.47% |
| Q2 2021 Q2Q % growth | -0.71 -12.70% | -0.76 | 0.05 | 7.07% |
| Q1 2021 Q2Q % growth | -0.77 1.28% | -0.73 | -0.04 | -6.17% |
| Q4 2020 Q2Q % growth | -0.59 22.37% | -0.60 | 0.01 | 2.29% |
| Q3 2020 Q2Q % growth | -0.73 -8.96% | -0.74 | 0.01 | 1.01% |
| Q2 2020 Q2Q % growth | -0.63 11.27% | -0.59 | -0.04 | -6.31% |
| Q1 2020 Q2Q % growth | -0.78 28.44% | -0.71 | -0.07 | -10.23% |
| Q4 2019 Q2Q % growth | -0.76 | -0.68 | -0.08 | -11.21% |
| Q3 2019 Q2Q % growth | -0.67 | -0.84 | 0.17 | 20.50% |
| Q2 2019 Q2Q % growth | -0.71 | -1.00 | 0.29 | 29.29% |
| Q1 2019 Q2Q % growth | -1.09 | -0.89 | -0.20 | -22.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 30.54M -9.50% | 35.562M | -5.022M | -14.12% |
| Q3 2024 Q2Q % growth | 38.783M 7.70% | 38.544M | 239K | 0.62% |
| Q2 2024 Q2Q % growth | 42.786M 13.86% | 36.903M | 5.883M | 15.94% |
| Q1 2024 Q2Q % growth | 33.126M -14.40% | 35.162M | -2.036M | -5.79% |
| Q4 2023 Q2Q % growth | 33.747M 0.44% | 36.113M | -2.366M | -6.55% |
| Q3 2023 Q2Q % growth | 36.009M -0.25% | 38.025M | -2.016M | -5.30% |
| Q2 2023 Q2Q % growth | 37.579M -5.34% | 36.736M | 843K | 2.29% |
| Q1 2023 Q2Q % growth | 38.698M -18.87% | 37.337M | 1.361M | 3.65% |
| Q4 2022 Q2Q % growth | 33.6M -73.40% | 35.821M | -2.221M | -6.20% |
| Q3 2022 Q2Q % growth | 36.1M -4.24% | 35.253M | 847K | 2.40% |
| Q2 2022 Q2Q % growth | 39.7M 75.66% | 36.303M | 3.397M | 9.36% |
| Q1 2022 Q2Q % growth | 47.7M 104.72% | 34.854M | 12.846M | 36.86% |
| Q4 2021 Q2Q % growth | 126.3M 259.83% | 40.868M | 85.432M | 209.04% |
| Q3 2021 Q2Q % growth | 37.7M 77.00% | 26.32M | 11.38M | 43.24% |
| Q2 2021 Q2Q % growth | 22.6M -32.54% | 26.153M | -3.553M | -13.59% |
| Q1 2021 Q2Q % growth | 23.3M 28.73% | 25.672M | -2.372M | -9.24% |
| Q4 2020 Q2Q % growth | 35.1M 93.92% | 29.961M | 5.139M | 17.15% |
| Q3 2020 Q2Q % growth | 21.3M 62.60% | 21.882M | -582K | -2.66% |
| Q2 2020 Q2Q % growth | 33.5M 252.63% | 27.97M | 5.53M | 19.77% |
| Q1 2020 Q2Q % growth | 18.1M 8,950.00% | 21.708M | -3.608M | -16.62% |
| Q4 2019 Q2Q % growth | 18.1M | 16.667M | 1.433M | 8.60% |
| Q3 2019 Q2Q % growth | 13.1M | 1.838M | 11.262M | 612.73% |
| Q2 2019 Q2Q % growth | 9.5M | 96.104K | 9.404M | 9,785.08% |
| Q1 2019 Q2Q % growth | 200K | 334.662K | -134.662K | -40.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.9% | -5.9% | -2.51% | 4.63% |
| Revenue | -8.32% | -8.32% | -0.95% | -2.07% |